DUBLIN--(BUSINESS WIRE)--The "Proteomics Market by Instrument (Spectroscopy, Chromatography, Electrophoresis, Microfluidics, X-ray Crystallography), Reagents, Services & Software (Protein Identification, Characterization, Bioinformatics), Application - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.
An increase in the research activity, especially in the area of personalized medicine and drug discovery is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the growth of the proteomics market.
The growing prominence of nanoproteomics and personalized proteomics for precision health offers significant growth opportunities for players in this market. However, low biomarker discovery-to-approval ratio and data management in proteomics research are some of the major market challenges.
The protein fractionation segment is expected to grow at the highest rate during the forecast period.
Based on instrumentation technology, the proteomics market is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The protein fractionation segment is projected to witness the highest growth in the proteomics market during the forecast period.
This growth is attributed to the benefits of protein fractionation, such as its ability to effectively separate thousands of proteins in a complex structure. The need for the analysis of complex mixtures comprising proteins is increasing in proteomics research; this serves to drive the market demand for protein fractionation systems.
The bioinformatics software & services segment is expected to grow at the highest CAGR during the forecast period.
Based on services and software, the proteomics market is segmented into core proteomics services and bioinformatics software & services. The bioinformatics software & services segment is projected to witness the highest growth rate during the forecast period.
With the exponential growth in the determination of protein sequences and structures via genome sequencing and structural genomics efforts, there is a growing need for reliable computational methods to determine the biochemical function of these proteins. This is expected to drive the growth of the bioinformatics segment in the coming years.
APAC is projected to witness the highest growth during the forecast period.
Even though North America is expected to account for the largest share of the global proteomics market in 2018, APAC is expected to witness the highest CAGR during the forecast period.
The growing Asian scientific base and capability, growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, growing awareness about personalized therapeutics, and increasing research activities in the field of mAb-based therapeutics are factors driving the growth of this regional segment.
The proteomics market is highly competitive, with a number of players competing for a larger market share. The prominent players in this market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Creative Proteomics (US), and Promega Corporation (US).
Due to the intense competition in this market, major market players are increasingly focusing on expanding their geographic presence in the high-growth emerging markets and strengthening their competitiveness in the market by acquiring smaller players with desired manufacturing capabilities or geographic presence.
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Proteomics: Market Overview
4.2 Proteomics Market: Geographic Growth Opportunities
4.3 Regional Mix: Proteomics Market (2019-2024)
4.4 Proteomics Market: Developed vs Developing Markets, 2019 vs 2024
5 Market Overview
5.2.1 Market Drivers
22.214.171.124 Increasing Demand for Personalized Medicine
126.96.36.199 Proteomics Bridges the Gap Between Genomics and Biochemistry
188.8.131.52 Increasing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding for Proteomics
184.108.40.206 Technological Advancements
5.2.2 Market Restraints
220.127.116.11 High Cost of Instruments
5.2.3 Market Opportunities
18.104.22.168 Growing Prominence of Nanoproteomics - The Convergence of Nanotechnology and Proteomics
22.214.171.124 Personalized Proteomics for Precision Health
126.96.36.199 High Growth Opportunities in Emerging Countries
5.2.4 Market Challenges
188.8.131.52 Data Management in Proteomics Research
184.108.40.206 Low Biomarker Discovery-To-Approval Ratio
6 Industry Insights
6.2 Industry Trends
6.2.1 Integration of Omics Data in Biomedical Sciences
6.2.2 Growing Focus on Monitoring Post-Translational Modifications
6.2.3 Increasing Uptake of Label-Free Quantification Techniques
6.2.4 Integrating Networks and Proteomics
6.3 Unmet Needs Analysis
6.3.1 Challenges in Analyzing Low Abundance Proteins
7 Proteomics Market, By Instrumentation Technology
7.5 Protein Microarrays
7.6 X-Ray Crystallography
7.7 Surface Plasmon Resonance
7.8 Protein Fractionation
8 Proteomics Market, By Reagent
8.2 Immunoassay Reagents
8.3 Spectroscopy Reagents
8.4 Chromatography Reagents
8.5 Protein Microarray Reagents
8.6 X-Ray Crystallography Reagents
8.7 Electrophoresis Reagents
8.8 Protein Fractionation Reagents
9 Proteomics Market, By Services & Software
9.2 Core Proteomics Services
9.3 Bioinformatics Software & Services
10 Proteomics Market, By Application
10.2 Clinical Diagnostics
10.3 Drug Discovery
10.4 Other Applications
11 Proteomics Market, By Region
11.2 North America
11.4 Asia Pacific
11.5 Latin America
11.6 Middle East & Africa
12 Competitive Landscape
12.2 Market Share Analysis
12.3 Competitive Leadership Mapping
12.4 Competitive Situation and Trends
13 Company Profiles
13.1 Thermo Fisher Scientific Inc.
13.2 Agilent Technologies Inc.
13.3 Merck KGaA
13.4 Danaher Corporation
13.5 Waters Corporation
13.6 Bio-Rad Laboratories Inc.
13.7 Bruker Corporation
13.8 GE Healthcare
13.9 Perkinelmer Inc.
13.10 Luminex Corporation
13.11 Creative Proteomics
13.12 Promega Corporation
For more information about this report visit https://www.researchandmarkets.com/research/pd58gj/global_proteomics?w=4